A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
In a mouse and human-cell study, the omega-3-derived molecule Resolvin D5 helped clear pneumonia-causing bacteria while reducing harmful lung inflammation, including when combined with antibiotics.
Omega-3-enriched nutrition supplements were linked to better weight maintenance and blood cell counts in malnourished GI cancer patients, but not clearer inflammation improvement.
Eating seafood, EPA, and DHA at breakfast and lunch was linked to a more 'morning type' sleep pattern and less weekday-weekend sleep mismatch.
In rats with kidney disease, DHA combined with captopril reduced heart damage and inflammation caused by a gut-derived uremic toxin.
A membrane-based cell retention system boosted algae-derived DHA output nearly 8-fold when growing Schizochytrium on waste-derived fermentation fluid.
A research review compares heart-failure and atrial fibrillation drugs to natural compounds like omega-3s and plant polyphenols that may act on similar inflammation and oxidative stress pathways.
People with an omega-3-depleted fatty acid profile had more fragile arterial plaques and higher heart attack/stroke risk despite having lower LDL cholesterol.
In lab-grown gut tissue models, an omega-3 (EPA:DHA) and EGCG combination modified obesity-related cancer stem cell signaling patterns linked to colorectal cancer.
A malaria-related compound also abbreviated 'DHA' (not omega-3 DHA) was shown in lab and rodent studies to trigger copper- and iron-related cell death pathways in liver stellate cells, a mechanism relevant to liver fibrosis research.